TP53 and breast cancer: The TP53 variant carriers identified using the GC‐HBOC criteria mostly were from families with two women who developed unilateral BC, with one who developed the disease before the age of 50 years (69%), and at least one woman who developed unilateral BC before the age of 36 years (57%).